BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 2 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

Recs

0
Player Avatar TrackMagicFormul (87.58) Submitted: 11/14/2012 1:20:11 PM : Outperform Start Price: $4.22 BDSI Score: +12.82

Investors should consider selling puts. You can achieve some very high annualized returns at strikes significantly below the current price. e.g.

June 13 $2.50 strike at 30¢ has 47% discount and 20% annualized return.

Member Avatar TrackMagicFormul (87.58) Submitted: 7/24/2013 7:48:41 AM
Recs: 0

Stock never fell below $3.50 the whole time. Expired profitably, and if had been paying attention, probably became near-worthless long before June.

Featured Broker Partners


Advertisement